GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Shiller PE Ratio

Rohto Pharmaceutical Co (TSE:4527) Shiller PE Ratio : 31.04 (As of May. 04, 2025)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Shiller PE Ratio?

As of today (2025-05-04), Rohto Pharmaceutical Co's current share price is 円2418.50. Rohto Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was 円77.92. Rohto Pharmaceutical Co's Shiller PE Ratio for today is 31.04.

The historical rank and industry rank for Rohto Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4527' s Shiller PE Ratio Range Over the Past 10 Years
Min: 27.82   Med: 38.72   Max: 62.06
Current: 31.04

During the past years, Rohto Pharmaceutical Co's highest Shiller PE Ratio was 62.06. The lowest was 27.82. And the median was 38.72.

TSE:4527's Shiller PE Ratio is ranked worse than
71.8% of 1007 companies
in the Consumer Packaged Goods industry
Industry Median: 17.96 vs TSE:4527: 31.04

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rohto Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was 円19.390. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円77.92 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Rohto Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Rohto Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Shiller PE Ratio Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.77 31.99 35.31 44.77 40.69

Rohto Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.11 40.69 43.83 45.84 -

Competitive Comparison of Rohto Pharmaceutical Co's Shiller PE Ratio

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Rohto Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Rohto Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2418.50/77.92
=31.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Rohto Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=19.39/108.9000*108.9000
=19.390

Current CPI (Sep. 2024) = 108.9000.

Rohto Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 9.995 97.900 11.118
201503 12.205 97.900 13.576
201506 5.820 98.400 6.441
201509 15.530 98.500 17.170
201512 12.850 98.100 14.265
201603 5.650 97.900 6.285
201606 6.010 98.100 6.672
201609 12.330 98.000 13.701
201612 18.470 98.400 20.441
201703 6.975 98.100 7.743
201706 9.945 98.500 10.995
201709 14.740 98.800 16.247
201712 19.470 99.400 21.331
201803 -3.565 99.200 -3.914
201806 15.035 99.200 16.505
201809 16.945 99.900 18.472
201812 15.535 99.700 16.969
201903 -4.700 99.700 -5.134
201906 9.690 99.800 10.574
201909 22.240 100.100 24.195
201912 22.980 100.500 24.901
202003 12.445 100.300 13.512
202006 7.635 99.900 8.323
202009 17.705 99.900 19.300
202012 21.460 99.300 23.535
202103 26.380 99.900 28.757
202106 20.760 99.500 22.721
202109 27.415 100.100 29.825
202112 26.605 100.100 28.944
202203 17.560 101.100 18.915
202206 30.560 101.800 32.691
202209 27.100 103.100 28.625
202212 36.910 104.100 38.612
202303 20.720 104.400 21.613
202306 39.730 105.200 41.127
202309 32.800 106.200 33.634
202312 41.800 106.800 42.622
202403 20.880 107.200 21.211
202406 37.080 108.200 37.320
202409 19.390 108.900 19.390

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rohto Pharmaceutical Co  (TSE:4527) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Rohto Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co Headlines

No Headlines